ARCHIVES

DCT Board Approves Concepts Of Eight New Biological Response Modifiers Program

This article is from The Cancer Letter archive.

Vol. 07 No. 27 | July 3, 1981

Download PDF Visit The Full Archive

Related Articles

In Brief: Gigliotti Named Greenwald Special Assistant; Coltman To Get ACCC Clinical Research Award

August 26, 1988

Pharmacia Corp. Forms $1 Million Fund To Support Anthracycline Research.

June 2, 2000

Pancreatic Cancer Treatment Shows Postive Early Results

December 30, 2005

DCPC Board Defers Decision On Hepatitis Vaccine Study, Rejects PAP Sensitivity Concepts

June 1, 1984

FDA Approves Large-Volume Processor For Cytyc’s ThinPrep Pap Test Samples.

June 30, 2000

NCAB Approves Plan for National Black Leadership Initiative

October 16, 1987